Genetic correction of PSA values using sequence variants associated with PSA levels
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field Measuring serum levels of the prostate-specific antigen (PSA) is the most common screening method for prostate cancer. However, PSA levels are affected by a number of factors apart from neo...
Published in: | Science Translational Medicine |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
American Association for the Advancement of Science
2011
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/128035 https://doi.org/10.1126/scitranslmed.3001513 |
id |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/128035 |
---|---|
record_format |
openpolar |
institution |
Open Polar |
collection |
Hirsla - Landspítali University Hospital research archive |
op_collection_id |
ftlandspitaliuni |
language |
English |
topic |
Early Detection of Cancer Genetic Markers Humans Kallikreins Male Polymorphism Single Nucleotide Prostate-Specific Antigen Prostatic Neoplasms Prostatic Secretory Proteins Receptor Fibroblast Growth Factor Type 2 T-Box Domain Proteins Telomerase Tumor Markers Biological |
spellingShingle |
Early Detection of Cancer Genetic Markers Humans Kallikreins Male Polymorphism Single Nucleotide Prostate-Specific Antigen Prostatic Neoplasms Prostatic Secretory Proteins Receptor Fibroblast Growth Factor Type 2 T-Box Domain Proteins Telomerase Tumor Markers Biological Gudmundsson, Julius Besenbacher, Soren Sulem, Patrick Gudbjartsson, Daniel F Olafsson, Isleifur Arinbjarnarson, Sturla Agnarsson, Bjarni A Benediktsdottir, Kristrun R Isaksson, Helgi J Kostic, Jelena P Gudjonsson, Sigurjon A Stacey, Simon N Gylfason, Arnaldur Sigurdsson, Asgeir Holm, Hilma Bjornsdottir, Unnur S Eyjolfsson, Gudmundur I Navarrete, Sebastian Fuertes, Fernando Garcia-Prats, Maria D Polo, Eduardo Checherita, Ionel A Jinga, Mariana Badea, Paula Aben, Katja K Schalken, Jack A van Oort, Inge M Sweep, Fred C Helfand, Brian T Davis, Michael Donovan, Jenny L Hamdy, Freddie C Kristjansson, Kristleifur Gulcher, Jeffrey R Masson, Gisli Kong, Augustine Catalona, William J Mayordomo, Jose I Geirsson, Gudmundur Einarsson, Gudmundur V Barkardottir, Rosa B Jonsson, Eirikur Jinga, Viorel Mates, Dana Kiemeney, Lambertus A Neal, David E Thorsteinsdottir, Unnur Rafnar, Thorunn Stefansson, Kari Genetic correction of PSA values using sequence variants associated with PSA levels |
topic_facet |
Early Detection of Cancer Genetic Markers Humans Kallikreins Male Polymorphism Single Nucleotide Prostate-Specific Antigen Prostatic Neoplasms Prostatic Secretory Proteins Receptor Fibroblast Growth Factor Type 2 T-Box Domain Proteins Telomerase Tumor Markers Biological |
description |
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field Measuring serum levels of the prostate-specific antigen (PSA) is the most common screening method for prostate cancer. However, PSA levels are affected by a number of factors apart from neoplasia. Notably, around 40% of the variability of PSA levels in the general population is accounted for by inherited factors, suggesting that it may be possible to improve both sensitivity and specificity by adjusting test results for genetic effects. To search for sequence variants that associate with PSA levels, we performed a genome-wide association study and follow-up analysis using PSA information from 15,757 Icelandic and 454 British men not diagnosed with prostate cancer. Overall, we detected a genome-wide significant association between PSA levels and single-nucleotide polymorphisms (SNPs) at six loci: 5p15.33 (rs2736098), 10q11 (rs10993994), 10q26 (rs10788160), 12q24 (rs11067228), 17q12 (rs4430796), and 19q13.33 [rs17632542 (KLK3: I179T)], each with P(combined) <3 × 10(-10). Among 3834 men who underwent a biopsy of the prostate, the 10q26, 12q24, and 19q13.33 alleles that associate with high PSA levels are associated with higher probability of a negative biopsy (odds ratio between 1.15 and 1.27). Assessment of association between the six loci and prostate cancer risk in 5325 cases and 41,417 controls from Iceland, the Netherlands, Spain, Romania, and the United States showed that the SNPs at 10q26 and 12q24 were exclusively associated with PSA levels, whereas the other four loci also were associated with prostate cancer risk. We propose that a personalized PSA cutoff value, based on genotype, should be used when deciding to perform a prostate biopsy. info:eu-repo/grantAgreement/EC/FP7/202059/ 218071 Urological Research Foundation P50 CA90386-05S2 Robert H. Lurie Comprehensive Cancer Center p30 CA60553 Health Technology Assessment Programme 96/20/06 96/20/99 Department of Health, England Cancer Research ... |
author2 |
deCODE genetics, IS-101 Reykjavik, Iceland. julius@decode.is |
format |
Article in Journal/Newspaper |
author |
Gudmundsson, Julius Besenbacher, Soren Sulem, Patrick Gudbjartsson, Daniel F Olafsson, Isleifur Arinbjarnarson, Sturla Agnarsson, Bjarni A Benediktsdottir, Kristrun R Isaksson, Helgi J Kostic, Jelena P Gudjonsson, Sigurjon A Stacey, Simon N Gylfason, Arnaldur Sigurdsson, Asgeir Holm, Hilma Bjornsdottir, Unnur S Eyjolfsson, Gudmundur I Navarrete, Sebastian Fuertes, Fernando Garcia-Prats, Maria D Polo, Eduardo Checherita, Ionel A Jinga, Mariana Badea, Paula Aben, Katja K Schalken, Jack A van Oort, Inge M Sweep, Fred C Helfand, Brian T Davis, Michael Donovan, Jenny L Hamdy, Freddie C Kristjansson, Kristleifur Gulcher, Jeffrey R Masson, Gisli Kong, Augustine Catalona, William J Mayordomo, Jose I Geirsson, Gudmundur Einarsson, Gudmundur V Barkardottir, Rosa B Jonsson, Eirikur Jinga, Viorel Mates, Dana Kiemeney, Lambertus A Neal, David E Thorsteinsdottir, Unnur Rafnar, Thorunn Stefansson, Kari |
author_facet |
Gudmundsson, Julius Besenbacher, Soren Sulem, Patrick Gudbjartsson, Daniel F Olafsson, Isleifur Arinbjarnarson, Sturla Agnarsson, Bjarni A Benediktsdottir, Kristrun R Isaksson, Helgi J Kostic, Jelena P Gudjonsson, Sigurjon A Stacey, Simon N Gylfason, Arnaldur Sigurdsson, Asgeir Holm, Hilma Bjornsdottir, Unnur S Eyjolfsson, Gudmundur I Navarrete, Sebastian Fuertes, Fernando Garcia-Prats, Maria D Polo, Eduardo Checherita, Ionel A Jinga, Mariana Badea, Paula Aben, Katja K Schalken, Jack A van Oort, Inge M Sweep, Fred C Helfand, Brian T Davis, Michael Donovan, Jenny L Hamdy, Freddie C Kristjansson, Kristleifur Gulcher, Jeffrey R Masson, Gisli Kong, Augustine Catalona, William J Mayordomo, Jose I Geirsson, Gudmundur Einarsson, Gudmundur V Barkardottir, Rosa B Jonsson, Eirikur Jinga, Viorel Mates, Dana Kiemeney, Lambertus A Neal, David E Thorsteinsdottir, Unnur Rafnar, Thorunn Stefansson, Kari |
author_sort |
Gudmundsson, Julius |
title |
Genetic correction of PSA values using sequence variants associated with PSA levels |
title_short |
Genetic correction of PSA values using sequence variants associated with PSA levels |
title_full |
Genetic correction of PSA values using sequence variants associated with PSA levels |
title_fullStr |
Genetic correction of PSA values using sequence variants associated with PSA levels |
title_full_unstemmed |
Genetic correction of PSA values using sequence variants associated with PSA levels |
title_sort |
genetic correction of psa values using sequence variants associated with psa levels |
publisher |
American Association for the Advancement of Science |
publishDate |
2011 |
url |
http://hdl.handle.net/2336/128035 https://doi.org/10.1126/scitranslmed.3001513 |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
info:eu-repo/grantAgreement/EC/FP7/202059/ 218071 http://dx.doi.org/10.1126/scitranslmed.3001513 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564581/ Sci Transl Med. 2010, 2(62):62ra92 1946-6242 21160077 doi:10.1126/scitranslmed.3001513 http://hdl.handle.net/2336/128035 Science translational medicine |
op_doi |
https://doi.org/10.1126/scitranslmed.3001513 |
container_title |
Science Translational Medicine |
container_volume |
2 |
container_issue |
62 |
_version_ |
1766043184536748032 |
spelling |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/128035 2023-05-15T16:52:47+02:00 Genetic correction of PSA values using sequence variants associated with PSA levels Gudmundsson, Julius Besenbacher, Soren Sulem, Patrick Gudbjartsson, Daniel F Olafsson, Isleifur Arinbjarnarson, Sturla Agnarsson, Bjarni A Benediktsdottir, Kristrun R Isaksson, Helgi J Kostic, Jelena P Gudjonsson, Sigurjon A Stacey, Simon N Gylfason, Arnaldur Sigurdsson, Asgeir Holm, Hilma Bjornsdottir, Unnur S Eyjolfsson, Gudmundur I Navarrete, Sebastian Fuertes, Fernando Garcia-Prats, Maria D Polo, Eduardo Checherita, Ionel A Jinga, Mariana Badea, Paula Aben, Katja K Schalken, Jack A van Oort, Inge M Sweep, Fred C Helfand, Brian T Davis, Michael Donovan, Jenny L Hamdy, Freddie C Kristjansson, Kristleifur Gulcher, Jeffrey R Masson, Gisli Kong, Augustine Catalona, William J Mayordomo, Jose I Geirsson, Gudmundur Einarsson, Gudmundur V Barkardottir, Rosa B Jonsson, Eirikur Jinga, Viorel Mates, Dana Kiemeney, Lambertus A Neal, David E Thorsteinsdottir, Unnur Rafnar, Thorunn Stefansson, Kari deCODE genetics, IS-101 Reykjavik, Iceland. julius@decode.is 2011-04-13 http://hdl.handle.net/2336/128035 https://doi.org/10.1126/scitranslmed.3001513 en eng American Association for the Advancement of Science info:eu-repo/grantAgreement/EC/FP7/202059/ 218071 http://dx.doi.org/10.1126/scitranslmed.3001513 http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564581/ Sci Transl Med. 2010, 2(62):62ra92 1946-6242 21160077 doi:10.1126/scitranslmed.3001513 http://hdl.handle.net/2336/128035 Science translational medicine Early Detection of Cancer Genetic Markers Humans Kallikreins Male Polymorphism Single Nucleotide Prostate-Specific Antigen Prostatic Neoplasms Prostatic Secretory Proteins Receptor Fibroblast Growth Factor Type 2 T-Box Domain Proteins Telomerase Tumor Markers Biological Article 2011 ftlandspitaliuni https://doi.org/10.1126/scitranslmed.3001513 2022-05-29T08:21:45Z To access publisher full text version of this article. Please click on the hyperlink in Additional Links field Measuring serum levels of the prostate-specific antigen (PSA) is the most common screening method for prostate cancer. However, PSA levels are affected by a number of factors apart from neoplasia. Notably, around 40% of the variability of PSA levels in the general population is accounted for by inherited factors, suggesting that it may be possible to improve both sensitivity and specificity by adjusting test results for genetic effects. To search for sequence variants that associate with PSA levels, we performed a genome-wide association study and follow-up analysis using PSA information from 15,757 Icelandic and 454 British men not diagnosed with prostate cancer. Overall, we detected a genome-wide significant association between PSA levels and single-nucleotide polymorphisms (SNPs) at six loci: 5p15.33 (rs2736098), 10q11 (rs10993994), 10q26 (rs10788160), 12q24 (rs11067228), 17q12 (rs4430796), and 19q13.33 [rs17632542 (KLK3: I179T)], each with P(combined) <3 × 10(-10). Among 3834 men who underwent a biopsy of the prostate, the 10q26, 12q24, and 19q13.33 alleles that associate with high PSA levels are associated with higher probability of a negative biopsy (odds ratio between 1.15 and 1.27). Assessment of association between the six loci and prostate cancer risk in 5325 cases and 41,417 controls from Iceland, the Netherlands, Spain, Romania, and the United States showed that the SNPs at 10q26 and 12q24 were exclusively associated with PSA levels, whereas the other four loci also were associated with prostate cancer risk. We propose that a personalized PSA cutoff value, based on genotype, should be used when deciding to perform a prostate biopsy. info:eu-repo/grantAgreement/EC/FP7/202059/ 218071 Urological Research Foundation P50 CA90386-05S2 Robert H. Lurie Comprehensive Cancer Center p30 CA60553 Health Technology Assessment Programme 96/20/06 96/20/99 Department of Health, England Cancer Research ... Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Science Translational Medicine 2 62 |